NEWS

11/21

7/21

St. Mary's Medical Center uses new stent tool to help stroke recovery

5/21

Wellstar First In Country To Use Blood Clot-Clearing Device

5/21

Rapid Medical Announces Closing of $50m Series D Financing

5/21

First US Ischemic Stroke Patients Treated with Rapid Medical’s Novel Clot Retriever

5/21

Wellstar docs use new tool to remove blood clots after strokes

4/21

St. Vincenz-Radiologie setzt kleinsten Stent-Retriever der Welt ein

3/21

Rapid Medical Receives FDA Clearance for the First Adjustable Stent Retriever for Use in Ischemic Stroke Treatment

3/21

TIGER Trial Demonstrates High Safety and Efficacy for World’s First Adjustable Thrombectomy Device

12/20

Rapid Medical Receives FDA Clearance for the World’s First Steerable Neurovascular Guidewire

11/20

Rapid Medical Expands Comaneci™ CE Mark Indication to Include Vasospasm Treatment

10/20

UVA neurosurgeon first in Virginia to use new device which could treat brain aneurysms more safely

10/20

The cutting edge: Technology updates

7/20

Rapid Medical Receives CE Mark for TIGERTRIEVER™ XL

6/20

Tigertriever® Revascularization Device Produced by Rapid Medical Ltd., an Affiliate Company of MicroPort® NeuroTech, Enters

4/20

Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device

12/19

Los Robles hospital treats stroke with new device

12/19

USA Health neurologist first in the state to perform new aneurysm procedure

12/19

USA Health neurologist first in the state to perform new aneurysm procedure

8/19

UMass doctors pilot first New England use of Israeli aneurysm device

8/19

The 1st International Distal Thrombectomy Summit called for a need to “define indications for distal thrombectomy and invest in registries”

7/19

Life-threatening brain aneurysm treated with first-in-U.S. device at Los Robles

6/19

Life-threatening brain aneurysm treated with first-in-U.S. device at Los Robles

5/19

Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device

4/19

Rapid Medical Raises $20 Million in New Funding to Support Clinical and Commercialization of First-in-class Stroke Treatment Products

7/18

Rapid Medical Receives CE Mark Approval for TIGERTRIEVER 13

5/18

Rapid Medical First Patient Enrolled to the TIGER Pivotal Clinical Study

7/17

Rapid Medical Announces $9M in New Funding to Advance Commercialization of First-In-Class Stroke Treatment Products

9/16

Rapid Medical's Comaneci Adjustable Remodeling Mesh Exceeds 500 Successful Aneurysm Treatments

1/16

Rapid Medical Announces First Stroke Patient Treated With TIGERTRIEVER

IN THE MEDIA